Midterm Review Meeting

On March 18, 2024, the STEPUPIORS consortium had a Midterm Review Meeting with the Project Officer Dr Irimie Doru-Leonard of the Research Executive Agency, European Commission, and an External Monitor Prof. Roman Volchenkov, from the University of Oslo, Norway. Main project results, deliverables, milestones and future plans were outlined by work package leaders and project managers from all partner institutions, in a friendly and stimulating atmosphere. The midterm report was approved by the REA EuC and the consortium participants look forward to next project steps.

 

STEPUPIORS midterm review participants:

Dr Ana Krivokuca, IORS, WP1 co-leader1
Dr Miljana Tanic, IORS, WP1 co-leader2
Dr Radmila Jankovic, IORS, WP2 leader
Prof. Ieronymos Zoidakis, BRFAA, WP3 leader
Dr Sergi Castellví-Bel, FRCB-IDIBAPS, WP4 leader
Dr Milena Cavic, IORS, WP5 leader/Project Coordinator
Dr Remond Fijneman, NKI-AVL PI
Dr Ana Djuric, IORS Project manager
Dr Meike de Wit, NKI-AVL Project manager
Dr Christos Ilioudis, BRFAA Project manager
Dr Joan Pallares, FRCB-IDIBAPS Project manager



STEPUPIORS at AACR2024 Congress

STEPUPIORS PIs Milena Cavic and Remond Fijneman presented latest project results and advancements in the colorectal cancer and liquid biopsy field at the science-packed AACR24 Congress of the American Association for Cancer Research, held from Apr 05-10, 2024 in San Diego, USA. Exciting discussions and plans for future projects on colorectal cancer predictive biomarkers were made with various stakeholders.
Cavic M, Djuric A, Marinkovic M, Stanojevic A, Tanic M, Bjelogrlic S, Spasic J, Damjanovic A,  Djordjic Crnogorac M, Vuletic A, Mirjacic Martinovic K, Radulovic M, Stojanovic-Rundic S, Krivokuca A, Jankovic R, Castellvi-Bel S, Zoidakis J, Fijneman R. Employing widening funds to address inequity in cancer research – example of the STEPUPIORS collaborative rectal cancer project [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 1304.https://doi.org/10.1158/1538-7445.AM2024-1304.

https://aacrjournals.org/cancerres/article/84/6_Supplement/1304/738874/Abstract-1304-Employing-widening-funds-to-address



Open day at IORS - focus on colorectal cancer in Serbia

On March 25, 2024, at 1 p.m., the Institute of Oncology and Radiology of Serbia will host an OPEN DAY on the topic of “Colon Cancer,” where our experts will try to answer all your questions.

We will talk about:
– how to recognize the symptoms of the disease in time
– how patients with colon cancer are treated today in the most modern way
– what is the role of the hereditary factor in the development of this disease
– how and when to seek psychological support

We will hear the story of our patient who was treated for colon cancer and underwent genetic testing at the Genetic Counseling Center of the Institute of Oncology and Radiology of Serbia.

The workshop is intended for patients, their family members, and anyone interested in expanding their knowledge on this topic.

Venue and time: Institute of Oncology and Radiology of Serbia, Society of Serbia for the Fight Against Cancer (ground floor), Pasterova 14, Belgrade, 03/25/2024 at 1 p.m.

All additional information can be obtained by phone number 011/2067-284, as well as by e-mail: geneticko.savetovanje.iors@ncrc.ac.rs



STEPUPIORS PIs featured in EACR's Cancer Researcher Magazine

STEPUPIORS PIs Milena Cavic, Jerome Zoidakis, Sergi Castellví-Bel and Remond J.A. Fijneman were featured in the Cancer Researcher Magazine of the European Association for Cancer Research. They presented project aims and first achievements, giving advice to a wide audience of over 12,000 EACR members on how to use widening funds to increase the visibility and excellence of cancer research across Europe.

https://magazine.eacr.org/how-to-use-widening-funds-to-increase-the-visibility-and-excellence-of-cancer-research-across-europe/



New scientific publications within WP2

1. Vuletić A, Mirjačić Martinović K, Spasić J. Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer. Pharmaceutics. 2024; 16(1):54. https://doi.org/10.3390/pharmaceutics16010054.


2. Marinkovic M, Stojanovic-Rundic S, Stanojevic A, Tomasevic A, Jankovic R, Zoidakis J, Castellví-Bel S, Fijneman RJA, Cavic M, Radulovic M. Performance and Dimensionality of Pretreatment MRI Radiomics in Rectal Carcinoma Chemoradiotherapy Prediction. Journal of Clinical Medicine. 2024; 13(2):421. doi.org/10.3390/jcm13020421.

https://www.mdpi.com/2077-0383/13/2/421


3. Stanojevic A, Spasic J, Marinkovic M, Stojanovic-Rundic S, Jankovic R, Djuric A, Zoidakis J, Fijneman RJA, Castellvi-Bel S and Cavic M (2024) Methylenetetrahydrofolate reductase polymorphic variants C677T and A1298C in rectal cancer in Slavic population: significance for cancer risk and response to chemoradiotherapy. Front. Genet. 14:1299599. doi: 10.3389/fgene.2023.1299599

https://www.frontiersin.org/articles/10.3389/fgene.2023.1299599/full



IORS Training and Strategic Visit to NKI-AVL

Milena Čavić performed a strategic training visit at the Netherlands Cancer Institute – Antoni van Leeuwenhoekziekenhuis (NKI AVL), Amsterdam, the Netherlands, in the period of December 06-09, 2023. The visit was focused on scientific activities concerning methods for ctDNA analysis of cancer patients’ samples and project management, exploring various aspects necessary for the implementation of the STEPUPIORS project, within work packages WP2, WP3 and WP5. The training was hosted by Dr Remond Fijneman from the Department for Pathology, Translational Gastrointestinal Oncology group, with contribution from various NKI AVL sectors.
During the visit, two external meetings were scheduled for December 07 and 08, 2023, respectively. The first meeting was held with the Dutch Cancer Society representatives (KWF Dutch Cancer Society) from Amsterdam, which provides support for Dutch researchers in applications for clinical, translational and basic science projects in the field of oncology. The second was focused on exploring the new health information system of the Netherlands – Health-Research Infrastructure (Health-RI Data Driven Health & Life Sciences) based in Utrecht, which is the new center of the Dutch health care system digitization.
New project applications were strategically planned during the visit and are expected in 2024 and 2025.



© 2023 STEPUPIORS. All rights reserved

Project ID:  101079217 (HORIZON-WIDERA-2021-ACCESS-03)

Funded by the European Union. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the European Research Executive Agency can be held responsible for them

Project ID:  101079217 (HORIZON-WIDERA-2021-ACCESS-03)

Funded by the European Union. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the European Research Executive Agency can be held responsible for them

© 2023 STEPUPIORS. All rights reserved

Privacy Preference Center